Physician profile
Chitra Mony
NPI 1164624342
$1,634.12
in general payments reported to CMS, 2019-2025
25 companies · $566 in 2025
The $566 reported for 2025 was more than what 76% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $307 · 2020: $191 · 2021: $103 · 2022: $163 · 2023: $84.33 · 2024: $220 · 2025: $566.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $871.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $870.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $225.62 | 2024-2025 | Apligraf |
| Smith+Nephew, INC. | $164.18 | 2023-2025 | Collagenase Santyl, Acticoat 4" X 4", Allevyn Heel 10.5cm X 13.5cm Ctn 5 |
| Stryker Corporation | $139.58 | 2025 | Limflow System |
| Novartis Pharmaceuticals Corporation | $135.99 | 2019-2024 | |
| Pfizer INC. | $114.31 | 2019-2021 | |
| Abbvie INC. | $102.86 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $92.05 | 2022 | |
| Amgen INC. | $82.79 | 2019-2020 | |
| Kerecis Limited | $80.59 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Janssen Pharmaceuticals, INC | $62.48 | 2019 | |
| Astellas Pharma US INC | $59.14 | 2019-2020 | |
| Mylan Specialty L.P. | $58.84 | 2019-2022 | |
| Gilead Sciences, INC. | $47.75 | 2022 | |
| Solventum Corporation | $41.92 | 2024 | Activ.A.C. |
| Merck Sharp & Dohme LLC | $35.91 | 2020-2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $23.89 | 2025 | |
| Sanofi-Aventis U.S. LLC | $22.63 | 2019 | |
| Tactile Systems Technology INC | $21.81 | 2025 | Flexitouch Plus, Nimbl |
| Integra Lifesciences Corporation | $20.00 | 2025 | Tcc-Ez |
| Global Blood Therapeutics, INC. | $19.97 | 2021 | |
| Paratek Pharmaceuticals, INC. | $17.87 | 2025 | Nuzyra |
| Ets Wound Care LLC | $17.43 | 2025 | Mirragen Advanced Wound Matrix |
| Lilly USA, LLC | $16.30 | 2020 | |
| Vifor Pharma, INC. | $15.38 | 2020 | |
| Portola Pharmaceuticals, LLC | $14.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chitra Mony listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.